Search

everythinglearnresearchcommunity

for

Search:↓

New treatment using Minoxidil and EGCG with ionic liquids improves hair growth and quality for hair loss.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Taking Dutasteride with Ketoconazole can increase Dutasteride's effects and side effects.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Zinc is crucial for skin health and treating various skin disorders.

Finasteride-loaded proniosomes effectively promote hair growth in mice.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Supplemented Erzhi Wan may help regrow hair in male pattern baldness by affecting certain cell signaling pathways.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

ERG increases SOX9, promoting prostate cancer growth and invasion.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Blocking testosterone speeds up wound healing in males.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Sebocytes play a key role in controlling androgen levels in human skin.